News

Protagonist Announces Nomination of PN-477, an Oral and Injectable GLP-1R, GIPR, and GCGR Triple Agonist Peptide Development Candidate for Obesity
A novel oral peptide PN-477o with once-daily dosing, high potency and activation of glucagon-like peptide-1 (GLP-1), ...
Lehigh Valley Business19h
Dischinat retiring after decades leading Lehigh Valley workforce development
but she has always worked in the field in the previous workforce development agencies that preceded the Workforce Board as strategies changed and grew over the years. Pennsylvania CareerLink Lehigh ...